{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:24:42Z","timestamp":1787498682171,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004951","name":"Ataturk University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmcl.2026.130599","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:04:22Z","timestamp":1772309062000},"page":"130599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis of novel bromophenolic sulfonamides with their acetylcholinesterase and carbonic anhydrase inhibitory actions"],"prefix":"10.1016","volume":"136","author":[{"given":"Necla","family":"\u00d6zta\u015fk\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u0131n","family":"Ak\u0131nc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"\u00c7a\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"G\u00f6ksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lhami","family":"G\u00fcl\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130599_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-containing motifs for drug discovery: A critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202403434","article-title":"Sulfonamides as a promising scaffold in drug discovery: an insightful review on FDA-approved molecules, synthesis strategy, medical indication, and their binding mode","volume":"22","author":"Aslam","year":"2025","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmcl.2026.130599_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/pharmrev.123.000863","article-title":"Halogenated antimicrobial agents to combat drug-resistant pathogens","volume":"76","author":"Faleye","year":"2024","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmcl.2026.130599_bb0020","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-022-01786-0","article-title":"Lenacapavir: First approval","volume":"82","author":"Paik","year":"2022","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130599_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2471\/BLT.17.205807","article-title":"Monographs for medicines on WHO\u2019S model list of essential medicines","volume":"96","author":"Roth","year":"2018","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bmcl.2026.130599_bb0030","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1080\/00397911.2020.1802758","article-title":"Synthesis, characterization and biological activities of sulfonamide tagged 1,2,3-triazoles","volume":"50","author":"Kaushik","year":"2020","journal-title":"Synth Commun"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130599_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130599_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1358\/dot.2001.37.1.844180","article-title":"Almotriptan in the treatment of migraine","volume":"37","author":"Rabasseda","year":"2001","journal-title":"Drugs Today"},{"issue":"25","key":"10.1016\/j.bmcl.2026.130599_bb0045","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130599_bb0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmcl.2026.130599_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129290","article-title":"Discovery and development of benzene sulfonamide derivatives as anti-hepatic fibrosis agents","volume":"88","author":"Niu","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130599_bb0060","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1021\/jm4019614","article-title":"Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)- 2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities","volume":"57","author":"Lu","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0065","unstructured":"Bouche, L. A., Korr, D., Ter L. A., Fernandez-Montalvan, A. E., Barak, N., Hillig, R., Neuhaus, R., Gorjanacz, M., Puetter, V., Gradl, S. N., Herbert, S. A., Ferrara, S. J., Strathdee, C., Jaffe, J. D. Preparation of acyl sulfonamides for treating cancer. WIPO patent, 2020, WO2020216701. Chem. Abstr. 2020, 173, 866826."},{"key":"10.1016\/j.bmcl.2026.130599_bb0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejmech.2017.12.064","article-title":"Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site","volume":"144","author":"Du","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131927","article-title":"The effect of benzenesulfonamide\u2019s side chains on their human carbonic anhydrase I\/II inhibitory activities","volume":"1250","author":"Yang","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2026.130599_bb0080","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm021123s","article-title":"Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogeno sulfanilamide and halogeno phenyl amino benzolamide derivatives","volume":"46","author":"Ilies","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108938","article-title":"Synthesis of novel benzene bissulfonamides with carbonic anhydrase and choline esterase inhibitory properties","volume":"165","author":"Cano\u011flu","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0090","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1080\/07391102.2022.2148126","article-title":"Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study","volume":"41","author":"Homoud","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2026.130599_bb0095","unstructured":"Mrozik, H. H. Substituted benzenesulfonamides as anthelmintics. US Patent, 1977, US4005199, Chem. Abstr. 1977, 86, 171112."},{"key":"10.1016\/j.bmcl.2026.130599_bb0100","article-title":"Kinase inhibition via small molecule-induced intramolecular protein cross-linking","volume":"63","author":"Wang","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2026.130599_bb0105","unstructured":"Grandel, Roland; Braje, Wilfried Martin; Haupt, Andreas; Turner, Sean Colm; Lange, Udo; Drescher, Karla; Unger, Liliane; Plata, Dan. Preparation of (hetero)arylsulfonamides as modulators of serotonin 5HT6 receptors and dopamine D3 receptors for the treatment of CNS disorders. WIPO patent, 2007, WO2007118899. Chem. Abstr. 2007, 147, 486320."},{"key":"10.1016\/j.bmcl.2026.130599_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/mja2.50020","article-title":"Current management of glaucoma","volume":"210","author":"Lusthaus","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.bmcl.2026.130599_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ncl.2016.08.004","article-title":"Update on idiopathic intracranial hypertension","volume":"35","author":"Wall","year":"2017","journal-title":"Neurol Clin"},{"key":"10.1016\/j.bmcl.2026.130599_bb0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/jcm8030349","article-title":"Acetazolamide therapy in patients with heart failure: A meta-analysis","volume":"8","author":"Wongboonsin","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.bmcl.2026.130599_bb0125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2146\/ajhp170279","article-title":"Evaluating off-label uses of acetazolamide","volume":"75","author":"Van Berkel","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bmcl.2026.130599_bb0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/14756366.2015.1054820","article-title":"The effects of some bromophenol derivatives on human carbonic anhydrase isoenzymes","volume":"31","author":"Taslimi","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.hipert.2024.03.004","article-title":"Diuretics use in the management of hypertension","volume":"41","author":"Morales-Olivas","year":"2024","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.bmcl.2026.130599_bb0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-016-0559-2","article-title":"Dichlorphenamide: A review in primary periodic paralyses","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bmcl.2026.130599_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800150","article-title":"Synthesis of novel sulfamides incorporating phenethylamines and determination of their inhibition profiles against some metabolic enzymes","volume":"351","author":"Aksu","year":"2018","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2026.130599_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/14756366.2012.750311","article-title":"Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins","volume":"29","author":"Akbaba","year":"2014","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10426507.2024.2365702","article-title":"In silico and in vitro inhibition abilities of novel benzene sulfonamides on carbonic anhydrase and choline esterases","volume":"199","author":"Surgun","year":"2024","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0160","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.bmc.2013.03.077","article-title":"Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine","volume":"21","author":"Aksu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42457","volume":"11","author":"Amiranda","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.bmcl.2026.130599_bb0170","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/1389557520666200103100521","article-title":"Potent acetylcholinesterase inhibitors: potential drugs for Alzheimer\u2019s disease","volume":"20","author":"Ak\u0131nc\u0131o\u011flu","year":"2020","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14756366.2016.1189422","article-title":"Synthesis, acetylcholinesterase, butyrilcholinesterase, carbonic anhydrase inhibitory and metal chelating properties of some novel diaryl ether","volume":"31","author":"\u00d6zbey","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bioorg.2018.10.035","article-title":"Design, synthesis and bio evaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors","volume":"83","author":"Tanoli","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/0118715249278489231128042135","article-title":"Sulfonamide derivatives: recent compounds with potent anti-alzheimer\u2019s disease activity. Central nervous system agents in medicinal chemistry","volume":"24","author":"Egbujor","year":"2024","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.bmcl.2026.130599_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000496","article-title":"Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities","volume":"354","author":"G\u00f6k","year":"2021","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2026.130599_bb0195","article-title":"Synthesis of novel bromophenol with diaryl methanes-determination of their inhibition effects on carbonic anhydrase and acetylcholinesterase","volume":"27","author":"Oztaskin","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2026.130599_bb0200","doi-asserted-by":"crossref","first-page":"2300545","DOI":"10.1002\/ardp.202300545","article-title":"Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions","volume":"357","author":"El Ati","year":"2024","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2026.130599_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202302088","article-title":"Celecoxib derivatives containing pyrazole linked-sulfonamide moiety: carbonic anhydrase I\u2013II and acetylcholinesterase inhibition profiles","volume":"8","author":"Gerni","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2026.130599_bb0210","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1055\/s-0044-1796646","article-title":"Recent advances in the synthesis of sulfonamides intermediates","volume":"6","author":"Liu","year":"2024","journal-title":"Pharm Fronts"},{"key":"10.1016\/j.bmcl.2026.130599_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem Biol Drug Des"},{"issue":"24","key":"10.1016\/j.bmcl.2026.130599_bb0220","doi-asserted-by":"crossref","first-page":"13606","DOI":"10.1080\/07391102.2021.1991476","article-title":"Virtual screening of natural compounds as selective inhibitors of polo-like kinase-1 at C-terminal polo box and N-terminal catalytic domain","volume":"40","author":"Olawale","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2026.130599_bb0225","first-page":"205","article-title":"Synthesis of novel sulfamides derived from dopamine analogues with their in silico studies against hyperprolactinemia","volume":"17","author":"Naderi","year":"2024","journal-title":"Org Commun"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:55:17Z","timestamp":1777600517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S0960894X26000661"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130599","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel bromophenolic sulfonamides with their acetylcholinesterase and carbonic anhydrase inhibitory actions","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130599"}}